cdmo.directory
← Compare landing

Carbogen Amcis vs IDT Australia

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/carbogen-amcis/idtaus-com

CategoryCarbogen AmcisIDT Australia
Listed sitecdmocdmo
SummaryFull-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.IDT Australia delivers end-to-end cGMP CDMO solutions from active pharmaceutical ingredients to finished dosage forms, with integrated R&D, formulation, and manufacturing expertise for oral and injectable medicines.
Services
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Formulation Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Lyophilization (Freeze Drying)
  • Flow Chemistry & Continuous Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Vial Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Small Molecule Development & Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • ADC Payload & Linker Synthesis
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Formulation Development
  • Oral Solid Dosage Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Regulatory Affairs
  • CMC Regulatory Submission Support
  • Technology Transfer
Modalities
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
IndicationsData not yet provided.
  • Ophthalmology
  • Metabolic
  • Neurology
Locations
  • Bubendorf (Headquarters), Bubendorf, Basel-Landschaft, Switzerland
  • Aarau, Aarau, Aargau, Switzerland
  • Neuland, Hunzenschwil, Aargau, Switzerland
  • Vionnaz, Vionnaz, Valais, Switzerland
  • France, France, France
  • United Kingdom, United Kingdom, United Kingdom
  • Netherlands, Netherlands, Netherlands
  • China, China, China
  • Headquarters, Bubendorf, Basel-Landschaft, Switzerland
  • Switzerland, Switzerland, Switzerland
  • UK, UK, United Kingdom
  • France, France, France
  • Netherlands, Netherlands, Netherlands
  • Shanghai, Shanghai, Shanghai, China
Data not yet provided.
Certifications
  • NMPA · Identifier: GMP
  • NMPA · Identifier: GMP Compliance
  • NMPA · Identifier: GMP compliant
  • NMPA · Identifier: GMP Compliance (Shanghai site, unannounced inspection, no observations)
  • CIA · Identifier: Chemical Industries Association Recognition
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.